Related references
Note: Only part of the references are listed.The mitochondrial transcription factor TFAM in neurodegeneration: emerging evidence and mechanisms
Inhae Kang et al.
FEBS LETTERS (2018)
MPTP-induced parkinsonism: an historical case series (vol 17, pg 300, 2018)
J. Nannekes et al.
LANCET NEUROLOGY (2018)
Cellular Senescence Is Induced by the Environmental Neurotoxin Paraquat and Contributes to Neuropathology Linked to Parkinson's Disease
Shankar J. Chinta et al.
CELL REPORTS (2018)
MPTP-induced parkinsonism: an historical case series
Jorik Nonnekes et al.
LANCET NEUROLOGY (2018)
Sembragiline: A Novel, Selective Monoamine Oxidase Type B Inhibitor for the Treatment of Alzheimer's Diseases
Edilio Borroni et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)
α-Synuclein binds and sequesters PIKE-L into Lewy bodies, triggering dopaminergic cell death via AMPK hyperactivation
Seong Su Kang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
DOPAL derived alpha-synuclein oligomers impair synaptic vesicles physiological function
N. Plotegher et al.
SCIENTIFIC REPORTS (2017)
p53 isoforms regulate astrocyte-mediated neuroprotection and neurodegeneration
C. Turnquist et al.
CELL DEATH AND DIFFERENTIATION (2016)
Efficacy of rasagiline in early Parkinson's disease: a meta-analysis of data from the TEMPO and ADAGIO studies
Robert A. Hauser et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2016)
Long-term effects of rasagiline and the natural history of treated Parkinson's disease
Olivier Rascol et al.
MOVEMENT DISORDERS (2016)
Modelling the onset of senescence at the G1/S cell cycle checkpoint
Jose C. M. Mombach et al.
BMC GENOMICS (2014)
Catecholamine metabolism drives generation of mitochondrial DNA deletions in dopaminergic neurons
Johannes F. G. Neuhaus et al.
BRAIN (2014)
Lithium prevents parkinsonian behavioral and striatal phenotypes in an aged parkin mutant transgenic mouse model
Christopher A. Lieu et al.
BRAIN RESEARCH (2014)
Environmental stress, ageing and glial cell senescence: a novel mechanistic link to Parkinson's disease?
S. J. Chinta et al.
JOURNAL OF INTERNAL MEDICINE (2013)
Determinants of buildup of the toxic dopamine metabolite DOPAL in Parkinson's disease
David S. Goldstein et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Effect of diet on serotonergic neurotransmission in depression
Faisal Shabbir et al.
NEUROCHEMISTRY INTERNATIONAL (2013)
Selective binding of nuclear alpha-synuclein to the PGC1alpha promoter under conditions of oxidative stress may contribute to losses in mitochondrial function: Implications for Parkinson's disease
Almas Siddiqui et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
MAO-B elevation decreases parkin's ability to efficiently clear damaged mitochondria: protective effects of rapamycin
Almas Siddiqui et al.
FREE RADICAL RESEARCH (2012)
Astrocyte Senescence as a Component of Alzheimer's Disease
Rekha Bhat et al.
PLOS ONE (2012)
Controversies in Neurology: why monoamine oxidase B inhibitors could be a good choice for the initial treatment of Parkinson's disease
Matthias Loehle et al.
BMC NEUROLOGY (2011)
PARIS (ZNF746) Repression of PGC-1α Contributes to Neurodegeneration in Parkinson's Disease
Joo-Ho Shin et al.
CELL (2011)
Astrocytes in the aging brain express characteristics of senescence-associated secretory phenotype
Antero Salminen et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2011)
Neuroinflammation in Parkinson's disease
Etienne C. Hirsch et al.
PARKINSONISM & RELATED DISORDERS (2011)
The Promise of Neuroprotective Agents in Parkinson?s Disease
Stacey E. Seidl et al.
Frontiers in Neurology (2011)
MAO-inhibitors in Parkinson's Disease
Peter Riederer et al.
Experimental Neurobiology (2011)
Stress-induced senescence in human and rodent astrocytes
Alessandro Bitto et al.
EXPERIMENTAL CELL RESEARCH (2010)
Ability to delay neuropathological events associated with astrocytic MAO-B increase in a Parkinsonian mouse model: Implications for early intervention on disease progression
Almas Siddiqui et al.
NEUROBIOLOGY OF DISEASE (2010)
Platelet monoamine oxidase activity in children with attention-deficit/hyperactivity disorder
Gordana Nedic et al.
PSYCHIATRY RESEARCH (2010)
Lessons from the rotenone model of Parkinson's disease
J. Timothy Greenamyre et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2010)
Preferentially Increased Nitration of α-Synuclein at Tyrosine-39 in a Cellular Oxidative Model of Parkinson's Disease
Steven R. Danielson et al.
ANALYTICAL CHEMISTRY (2009)
Identifying the direct effects of ammonia on the brain
Cristina R. Bosoi et al.
METABOLIC BRAIN DISEASE (2009)
A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease
C. Warren Olanow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
MAO-B Elevation in Mouse Brain Astrocytes Results in Parkinson's Pathology
Jyothi K. Mallajosyula et al.
PLOS ONE (2008)
Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor
Jean-Philippe Coppe et al.
PLOS BIOLOGY (2008)
Aggregation of α-synuclein by DOPAL, the monoamine oxidase metabolite of dopamine
William J. Burke et al.
ACTA NEUROPATHOLOGICA (2008)
Astrocytes aged in vitro show a decreased neuroprotective capacity
M. Pertusa et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Epidemiology of Parkinson's disease
Lonneke M. L. de Lau et al.
LANCET NEUROLOGY (2006)
Respiration-dependent removal of exogenous H2O2 in brain mitochondria -: Inhibition by Ca2+
F Zoccarato et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation
MBH Youdim et al.
NEUROTOXICOLOGY (2004)
(-)-Deprenyl, a selective MAO-B inhibitor, with apoptotic and anti-apoptotic properties
K Magyar et al.
NEUROTOXICOLOGY (2004)
Association analysis of the functional monoamine oxidase A gene promotor polymorphism in migraine
M Marziniak et al.
JOURNAL OF NEURAL TRANSMISSION (2004)
Hydrogen peroxide removal and glutathione mixed disulfide formation during metabolic inhibition in mesencephalic cultures
J Ehrhart et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Reversible parkinsonism and hyperammonemia associated with portal vein thrombosis
P Federico et al.
ACTA NEUROLOGICA SCANDINAVICA (2001)
Anti-apoptotic and apoptotic action of (-)-deprenyl and its metabolites
B Szende et al.
JOURNAL OF NEURAL TRANSMISSION (2001)
Share Paper
